- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 45.54M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $47.72M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $47.5M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $3.97M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $5.93M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $18.1M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $27.55M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $21.75M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $30.61M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $90.8M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $99.82M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $93.07M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $99.22M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $196.17M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $203.73M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 43.23M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $924K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$12.27M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $93.16M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $95.67M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.15 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.15 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $9.96M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $7.41M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$6.64M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$4.56M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $32.62M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $8.76M |
| Revenue | Q1 2025 · Mar 31, 2024 | $41.38M |